Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors …
K Uryu, Y Imamura, R Shimoyama, T Mase… - Cancer Chemotherapy …, 2024 - Springer
Purpose This study aimed to examine the prognostic impact of concomitant pH-regulating
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …
[引用][C] Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase …
K Uryu, Y Imamura, R Shimoyama… - Cancer …, 2024 - da.lib.kobe-u.ac.jp
This version of the article has been accepted for publication, after peer review (when
applicable) and is subject to Springer Nature's AM terms of use, but is not the Version of …
applicable) and is subject to Springer Nature's AM terms of use, but is not the Version of …
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors …
K Uryu, Y Imamura, R Shimoyama… - Cancer … - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to examine the prognostic impact of concomitant pH-regulating
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors …
K Uryu, Y Imamura, R Shimoyama, T Mase… - Cancer …, 2024 - europepmc.org
Purpose This study aimed to examine the prognostic impact of concomitant pH-regulating
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …
drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non …